Skip to content

Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis

Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00957151
Enrollment
12
Registered
2009-08-12
Start date
2004-04-30
Completion date
2005-08-31
Last updated
2009-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pancreatitis

Keywords

chronic pancreatitis, exocrine pancreatic insufficiency, enzyme therapy, patients with chronic pancreatitis and exocrine pancreatic insufficiency, taking enzyme replacement therapy

Brief summary

The objective is to evaluate the dietary nitrogen assimilation and metabolic utilisation capability of patients with chronic pancreatitis.

Interventions

DRUGCreon

Sponsors

Solvay Pharmaceuticals
CollaboratorINDUSTRY
Hospital Avicenne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* subjects with chronic pancreatitis and taking enzyme replacement therapy

Exclusion criteria

* patients with hepatic impairment * patients allergic to dairy proteins * urinary incontinence affecting the measurement of nitrogen metabolism * digestive disorder affecting the absorption of nutrients

Design outcomes

Primary

MeasureTime frame
To measure digestive and metabolic assimilation of dietary proteins in patients with chronic pancreatitis

Secondary

MeasureTime frame
To determine the efficacy of enzyme therapy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026